Soluble CD40 ligand in haemodialysis patients: survival impact and cardiovascular prognostic role.
Soluble CD40 ligand (sCD40l) can predict cardiovascular events (CVE) and mortality in haemodialysis (HD) patients (short-, medium-term follow-up studies). To evaluate the relationship between sCD40l and survival, CVE and mortality in HD patients on long-term follow-up. We registered 46 HD patients' baseline characteristics, mortality and CVE for 108 months. SCD40l correlated positively with C-reactive protein, was higher in survivors, but had no impact on survival and was not predictive for CVE or CV mortality. The levels of sCD40l have no influence on survival or CVE and mortality in HD patients in a long-term follow-up.